[Corrigendum] Characteristics of primary side population cervical cancer cells

Wei,Zhen-Tong; Yu,Xiao-Wei; He,Jia-Xue; Liu,Yan; Zhang,Song-Ling

doi:10.3892/ol.2025.15293

December-2025 Volume 30 Issue 6

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

December-2025 Volume 30 Issue 6

Full Size Image

Correction Open Access

[Corrigendum] Characteristics of primary side population cervical cancer cells

Authors:
- Zhen-Tong Wei
- Xiao-Wei Yu
- Jia-Xue He
- Yan Liu
- Song-Ling Zhang
View Affiliations / Copyright

Affiliations: Department of Gynecological Oncology, The First Hospital of Jilin University, Changchun, Jilin 130021, P.R. China, Prenatal Diagnosis Center, The First Hospital of Jilin University, Changchun, Jilin 130021, P.R. China, Genetic Diagnosis Center, The First Hospital of Jilin University, Changchun, Jilin 130021, P.R. China, Genetic Engineering Laboratory of The Chinese People's Liberation Army, Military Veterinary Institute, Acadamy of Military Medical Sciences, Changchun, Jilin 130122, P.R. China

Copyright: © Wei et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].
Article Number: 547
|
Published online on: September 23, 2025

https://doi.org/10.3892/ol.2025.15293
Expand metrics +

Article

Oncol Lett 14: [Related article:] 3536–3544, 2017; DOI: 10.3892/ol.2017.6606

Following the publication of the above article, the authors have contacted the Editor to explain that, in the originally published version of Fig. 6 on p. 3543, concerning the tumorigenicity of SP and NSP cells from primary cervical cancer cells, three different injection cell quantities were applied for each type of cell. However, only two representative images were included in Fig. 6, and not the third image; the incomplete version of this figure was accidentally uploaded incorrectly owing to an oversight during the final manuscript assembly.

Figure 6.

Tumorigenicity assay for SP and NSP cells isolated from patient primary cervical cancer cells. (A) Image of a mouse with a tumor developed following injection of 1×103 SP cells and NSP cells. The SP cells were injected into the right forelimb, and NSP cells were injected into the left forelimbs of NOD-SCID mice. The mice were observed for 12 weeks. (B) Image of a mouse with a tumor developed following injection of 1×104 SP cells and NSP cells. The SP cells were injected into the right forelimb, and NSP cells were injected into the left forelimbs of NOD-SCID mice. The mice were observed for 12 weeks. (C) Image of a mouse with tumors developed following injection of 1×105 SP cells and NSP cells. Tumors developed in the right (SP cells) and left (NSP cells) forelimbs. NOD-SCID, non-obese diabetic/severe combined immunodeficiency; SP, side population; NSP, non-side population.

The revised version of Fig. 6, now showing the results of tumors developed following the injection of 1×105 SP cells and NSP cells in Fig. 6C, is shown on the next page. The authors regret the error that was made in assembling this figure, and thank the Editor of Oncology Letters for granting them the opportunity to publish this Corrigendum. All the authors agree with the publication of this Corrigendum, and apologize to the readership for any inconvenience caused.

Journals

International Journal of Molecular Medicine

International Journal of Oncology

Molecular Medicine Reports

Oncology Reports

Experimental and Therapeutic Medicine

Oncology Letters

Biomedical Reports

Molecular and Clinical Oncology

World Academy of Sciences Journal

International Journal of Functional Nutrition

International Journal of Epigenetics

Medicine International

[Corrigendum] Characteristics of primary side population cervical cancer cells

This article is mentioned in:

Article

Figure 6.

Related Articles